NCT00637299
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Fondazione Salvatore Maugeri Montescano, Pavia, Italy
Clinical trial condition
Chronic Obstructive Pulmonary Disease
Explore clinical trials studying Chronic Obstructive Pulmonary Disease. Study availability and eligibility vary by location and protocol.
1,229 public trials
84 recruiting studies
Chronic Obstructive Pulmonary Disease trial results
NCT00669617
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Tamarac, Florida, United States
- Novartis Investigator Site Lafayette, Louisiana, United States
- Novartis Investigative Site Saint Charles, Missouri, United States
- Novartis Investigative site Shelby, North Carolina, United States
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Berlin, Germany
- Novartis Investigator Site Mönchengladbach, Germany
- Novartis Investigator Site Wiesbaden, Germany
NCT01089127
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Florence, Alabama, United States
- Novartis Investigator Site Jasper, Alabama, United States
- Novartis Investigator Site Phoenix, Arizona, United States
- Novartis Investigator Site Searcy, Arkansas, United States
Completed
12-week Efficacy of Indacaterol
NCT01072448
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Peoria, Arizona, United States
- Novartis Investigator Site Pine Bluff, Arkansas, United States
- Novartis Investigator Site Buena Park, California, United States
- Novartis Investigator Site Encinitas, California, United States
Completed
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Research Site Rousse, Bulgaria
- Research Site Sofia, Bulgaria
- Research Site Helsinki, Finland
- Research Site Oulu, Finland
NCT00900731
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigator Site Jasper, Alabama, United States
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Tucson, Arizona, United States
NCT01068600
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Anniston, Alabama, United States
- Novartis Investigative Site Jasper, Alabama, United States
- Novartis Investigator Site Glendale, Arizona, United States
- Novartis Investigator Site Phoenix, Arizona, United States
Completed
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00624286
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Anniston, Alabama, United States
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Jasper, Alabama, United States
- Novartis Investigative Site Mobile, Alabama, United States
NCT00393458
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Buenos Aires, Argentina
- Novartis Buenos Aires, Argentina
- Novartis Investigator Site Mendoza, Argentina
- Novartis Investigator Site San Miguel, Argentina